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Alterations in Gastric Microbiota 
After H. Pylori Eradication and in 
Different Histological Stages of 
Gastric Carcinogenesis
Tung Hiu Li1, Youwen Qin2, Pak Chung Sham2, K.S. Lau1, Kent-Man Chu3 & Wai K. Leung1
The role of bacteria other than Helicobacter pylori (HP) in the stomach remains elusive. We characterized 
the gastric microbiota in individuals with different histological stages of gastric carcinogenesis and 
after receiving HP eradication therapy. Endoscopic gastric biopsies were obtained from subjects 
with HP gastritis, gastric intestinal metaplasia (IM), gastric cancer (GC) and HP negative controls. 
Gastric microbiota was characterized by Illumina MiSeq platform targeting the 16 S rDNA. Apart from 
dominant H. pylori, we observed other Proteobacteria including Haemophilus, Serratia, Neisseria and 
Stenotrophomonas as the major components of the human gastric microbiota. Although samples 
were largely converged according to the relative abundance of HP, a clear separation of GC and other 
samples was recovered. Whilst there was a strong inverse association between HP relative abundance 
and bacterial diversity, this association was weak in GC samples which tended to have lower bacterial 
diversity compared with other samples with similar HP levels. Eradication of HP resulted in an increase 
in bacterial diversity and restoration of the relative abundance of other bacteria to levels similar to 
individuals without HP. In conclusion, HP colonization results in alterations of gastric microbiota and 
reduction in bacterial diversity, which could be restored by antibiotic treatment.
Gastric cancer (GC) is the third commonest cause of cancer related death in the world1. In particular, more than 
half of GC related deaths occurred in East Asia. Although Helicobacter pylori (HP) has been classified as a group 
I carcinogen by the International Agency for Research on Cancer (IARC) more than two decades ago2, the exact 
mechanism underlying how HP induced gastric carcinogenesis remains poorly understood. Histologically, HP 
infection invariably leads to chronic gastritis, which progresses to atrophic gastritis (AG), intestinal metaplasia 
(IM), dysplasia and ultimately to cancer in some individuals3. Hence, AG and IM are generally considered to be 
premalignant gastric lesions.
Apart from HP, little is known about the role of other bacteria on the development of GC. Gastric atrophy has 
long been associated with bacterial overgrowth in the stomach due to the loss of gastric acidity. It has been shown 
that treatment with proton pump inhibitor could result in bacterial colonization of the stomach4. However, there 
are difficulties in characterizing these organisms in the stomach by traditional bacterial cultures in the past. With 
the availability of next generation sequencing (NGS), it is now possible to identify these previously unknown 
organisms in the stomach. Several studies have attempted to characterize the gastric microbiota in patients with 
and without HP infection as well as in patients with GC with conflicting results5–10, possibly due to the use of 
different platforms and in different patient’s groups. Moreover, it remains to be determined whether the disturbed 
gastric microbiota in HP infected subjects could be reversed by HP eradication therapy.
This study attempted to characterize the changes in gastric microbiota after HP eradication and the changes in 
gastric microbiota in individuals with different histological stages of gastric carcinogenesis.
Results
Patients’ samples. We sequenced 60 biopsy samples from 33 individuals including subjects 
with HP-associated chronic gastritis, gastric IM, gastric adenocarcinoma and HP-negative controls 
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(Supplementary Table 1). A total of 13,575,770 16 S rDNA V3-V4 sequencing reads were yielded. After a series of 
quality control processing, 6,228,692 (45.9%) high quality non-chimera reads were retained and were clustered 
into 874 non-singleton operational taxonomic units (OTUs). On average, each sample had 103,812 ± 45,764 reads 
and 135 ± 42 OTUs (Supplementary Table 2). The rarefaction analysis suggested that the sequencing depth has 
the ability to recover most of the community’s diversity (Supplementary Figure 1).
More than half of the reads (55.8%) were grouped into one OTU which was annotated as H. pylori. Together 
with 17 other OTUs which belonged to five phyla: Proteobacteria (13 OTUs), Bacteroidetes, Firmicutes, 
Fusobacteria and Actinobacteria, they accounted for 90.2% of the sequencing data. Moreover, these five phyla 
were mainly consisted of several genera (Supplementary Figure 2). Apart from these five major phyla, others 
were also identified in our dataset with low abundance (Supplementary Figure 3). At genus level, 19 genera 
were identified with average relative abundance > 0.5% (Fig. 1a). The high abundance genera were Helicobacter, 
Flavobacterium, Haemophilus, and Serratia.
The OTUs can be divided into several categories according to their occurrences among different sample 
groups (Fig. 1b). We identified 168 core OTUs which appeared in all histological groups. In total, these OTUs 
accounted for 99.1% (6,170,218/6,228,692) of the sequencing reads, suggesting that they are the major compo-
nents of the human gastric microbiota. Most of the core OTUs (135/168 = 80.4%) can be annotated to genus 
level, which was higher than the overall annotation rate (552/874 = 63.2%). On the other hand, the cancer group 
specific OTUs, were more likely to originate from unknown species.
Gastric Microbiota in Different Stages of Gastric Carcinogenesis. Proteobacteria was the dominant 
phylum in both HP negative and HP positive samples. While HP was the dominant bacterium in HP positive 
samples, other Proteobacteria including Haemophilus, Serratia, Neisseria, and Stenotrophomonas dominated the 
HP negative samples (Fig. 1a). Apart from HP, Eubacterium was found to be enriched in HP gastritis group. 
There was no significant difference in the bacterial compositions between the paired antrum and corpus samples. 
Figure 1. Genus composition and dispersion of 60 sequencing samples. (a) The relative abundance 
distribution of major genera across 60 sequencing samples. Only genera with relative abundance > 0.5% were 
shown, and the others were grouped into “Other” item. Genera were sorted by the decreasing order of average 
relative abundance. Samples were ordered according to their histological information. Samples with the same 
prefix were from the same individual. For IM samples, 1 indicates antral biopsy sample while 2 is corpus biopsy 
sample. For cancer samples, 1 indicates adjacent tissue biopsy sample while 2 is tumor biopsy sample. The “E” 
suffix represents samples after HP eradication. (b) The Veen plot of common OTUs among different group of 
samples. The number indicates the number of shared OTUs. (c) Principle coordinate analysis (PCoA) based on 
OTUs relative abundance profile. The variance explained by PC1 and PC2 are 55.3% and 13.3%, respectively. 
The distance was measured by root Jessen-Shannon divergence (rJSD). Points represent samples, and the color 
indicates group information. The accompany dendrogram was given in Supplementary Figure 5.
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Notably, both the paired antrum and corpus as well as the paired tumor and adjacent non-tumor tissue samples 
had considerably similar bacterial compositions as shown by PERMANOVA analysis (Supplementary Table 3).
In order to show the similarity of different samples, we performed PCoA analysis based on OTUs rela-
tive abundance profiles. The 2-D plot of the first two principal coordinates shows a clear divergence of can-
cer samples with other samples (Fig. 1c). This pattern remained even after removing the HP related OTUs 
(Supplementary Figure 4). HP gastritis samples overlapped with IM samples even after excluding HP OTUs.
OTU1, which belonged to HP, had the strongest negative correlation (Spearman correlation coefficient = − 
0.87, P < 1e-6) with the first principal coordinate. In addition to PCoA analysis, we conducted hierarchical clus-
tering analysis using four widely used distance metrics to avoid the bias of single distance metric and obtain 
consistently robust results. The dendrogram graphs show that samples were converged according to both HP 
and disease states (Supplementary Figure 5). While there is a clear dispersion of HP negative and HP positive 
samples, GC samples tended to group together. Although the effect of HP status was largely reduced by remov-
ing HP OTUs, the convergence of GC samples still remained (Supplementary Figure 6). The LEfSe analysis on 
OTUs identified 13 high abundance OTUs enriched in cancer samples compared with other histological sam-
ples (Supplementary Figure 7). These OTUs can be annotated to Flavobacterium, Klebsiella, Serratia marcescens, 
Stenotrophomnonas, Achromobacter and Pseudomonas. Taken together, there was a robust separation between GC 
samples and other samples.
Bacterial Diversity. Shannon entropy index and the phylogenetic diversity index were used to determine 
the bacterial diversity of different groups. The phylogenetic diversity index considers both phylogenetic tree dis-
tance and abundance. The normal group had the highest Shannon and phylogenetic diversity indices compared 
with chronic gastritis, IM and cancer groups (Fig. 2a and b), but the difference of Shannon index was larger than 
phylogenetic diversity index.
Effect of H. Pylori Eradication on Gastric Microbiota. Eleven HP-positive individuals with chronic 
gastritis or IM had serial biopsies taken before and eight weeks after receiving anti-HP treatment. The average 
relative abundance of Helicobactera decreased from 83.70% in the pre-treatment to 6.88% in the post treatment 
samples (Fig. 3a). Accordingly, the relative abundance of non-HP Proteobacteria has increased from 4.55% to 
51.70%. The relative abundance of other major phyla including Bacteroidetes, Fusobacteria and Actinobacteria 
were also found to be increased in post-eradication samples. Both the Shannon index and phylogenetic diversity 
index significantly increased after HP eradication (Fig. 3a).
Figure 2. Alpha diversity in different groups. (a) Boxplot of Shannon index in different groups. The boxes 
denote interquartile ranges (IQR) with the median as a black line and whiskers extending up to the most 
extreme points within 1.5 fold IQR. (b) Boxplot of phylogenetic diversity index in different groups. The 
meaning of box is the same with A. (c) The P-values between different groups were shown. Phylogenetic index 
stands for phylogenetic diversity index. Mann-Whitney test was used to calculate the P-value.
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Further analysis of the microbial composition between the post-eradication samples and the HP-negative con-
trols showed that the relative abundance of major phyla found in these two groups were very similar (Spearman 
correlation coefficient = 0.93, Fig. 3b). The same pattern was observed at the genus level (Spearman correlation 
coefficient = 0.83). While the HP OTU was dramatically reduced in the post eradication samples, the LEfSe anal-
ysis identified 32 major OTUs that were significantly changed after HP eradication (Fig. 3c). Apart from HP that 
was reduced after treatment, 31 OTUs were increased after HP eradication and most of these increasing OTUs 
belonged to Proteobacteria including OTU2 (Flavobacterium), OTU13 (Neisseria), OTU3 (Serratia) and OTU7 
(Fusobacterium) (Fig. 4).
Discussion
Although the stomach is generally considered to be hostile for the growth of bacteria, there is increasing evidence 
to suggest that the stomach also holds a core microbiome in addition to HP11,12. With the latest Miseq sequencing 
platform, this study attempted to characterize the gastric microbiota in various histological stages of the gastric 
carcinogenesis cascade. Moreover, we have demonstrated the effects of HP eradication on changes in gastric 
microbiota.
First, we found that phylum Proteobacteria is the dominant bacterial group in the stomach, irrespective of 
HP infection. While HP is the dominant species in HP positive subject, non-HP Proteobacteria bacteria were the 
major players, including Haemophilus, Serratia, Neisseria and Stenotrophomonas. Even in HP-negative individ-
uals as defined by conventional standard, some individuals still had low abundance of HP detected by the more 
sensitive NGS method, suggesting a false negative result by conventional biopsy based methods. The most striking 
difference between HP-infected and non-infected subjects was the difference in bacterial diversity, which was 
markedly reduced in HP-positive subjects. Moreover, the numbers of OTUs were also significantly lower in the 
HP-positive group, suggesting the dominance of HP infection. Previous reports that described the characteristics 
of gastric microbiota in HP infected subjects yielded conflicting results. Bik et al., by using the conventional 16 S 
rDNA clone library approach, found no significant difference in gastric microbiota between HP-positive and 
HP-negative subjects6. Andersson et al., however, showed a significant decrease in gastric microbiota diversity 
with HP infection by using 454 pyrosequencing technology, which was similar to our findings12. Despite potential 
difference in the distribution of HP between the antrum and corpus, we found that the corresponding gastric bac-
terial composition was very similar in both (Supplementary Table 3), which is in keeping with previous reports 
showing similar microbiota between the antrum and corpus5,6. Similar bacterial composition was also noted 
Figure 3. Alteration of the gastric microbiota after HP eradication. (a) Boxplot of the changes of HP relative 
abundance, Shannon index and phylogenetic diversity index before and after HP eradication. The black point 
indicates the sample, and the lines connected the paired samples of pre- and post-eradication. The meaning 
of box is the same with Fig. 2a. (b) Donut chart of major bacterial phyla in pre- and post-eradication samples, 
as well as normal control samples. (c) The barplot of significant OTUs with logarithmic LDA score. The OTUs 
were sorted according to the decreasing order of logarithmic LDA score. The taxonomic annotation of OTUs by 
RDP classifier was listed unless noted. The phylum column was colored according to phylum name.
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between tumor and adjacent non-tumorous region in patients with gastric cancer, further hinting on a common 
bacterial microenvironment of an individual’s stomach. We also demonstrated that age and gender of the subjects 
did not play a major role on bacterial composition of the stomach (Supplementary Table 3). In fact, the abundance 
of HP was found to have the utmost influence on the bacterial composition as well as diversity of the stomach.
Second, this is the first study to examine the serial changes in individual’s gastric microbiota before and after 
treatment for HP. We found that antibiotics treatment resulted in restoration of gastric microenvironment to that 
of HP-negative subject including similar phyla (genera) composition and an increase in the bacterial diversity 
index. If gastric dysbiosis plays a role on gastric carcinogenesis, eradication of HP could possibly restore the 
disturbed gastric homeostasis. Whilst there is increasing evidence to support the role of HP eradication in pre-
venting gastric cancer13, this novel observation further supports the potential beneficial effect of HP eradication 
on gastric cancer prevention.
Third, we had characterized the alterations in gastric microbiota during the progression from HP gastritis to 
IM and gastric cancer by Illumina MiSeq platform. Whilst there was an inverse association between HP abun-
dance and bacterial diversity in non-cancer gastric samples including normal, gastritis and IM, this inverse asso-
ciation was weak in cancer samples. Notably, the bacterial diversity was reduced in some cancer samples with low 
HP abundance. Two previous studies attempted to determine the bacterial diversity during the gastric cancer 
progression yielded conflicting results. Whilst one study showed progressive decline in microbial diversity dur-
ing progression from gastritis to cancer8, the other study found increased in bacterial diversity in this progres-
sion10. Although both studies examined the changes during the progression, they employed different platforms 
for microbiota characterization including microarray chip and 454 pyrosequencing. Moreover, the study popula-
tions and sample size were also different.
By hierarchal clustering based on four different distance metrics calculated on OTU abundance, we found 
that the segregation of samples of different histological changes were largely attributed by the presence of HP 
rather than the histological stages. Nevertheless, we still observed a separation of gastric cancer samples with 
other samples. The usage of multiple distance metrics can overcome the bias introduced by single distance metric, 
revealing the robust pattern of data. Previous studies demonstrated that the IM group was distributed in between 
the chronic gastritis and gastric cancer group8,10. Both studies showed that IM was found to overlap in the gastritis 
and cancer group by hierarchical clustering based on Weighted Unifrac distance and UPGMA clustering among 
patients with HP dominance. Our results showed that gastritis samples were largely overlapped with IM samples. 
The difference may lie on the recruitment of HP-positive subjects only in previous studies8,10. The use of a more 
robust sequencing platform in our study, which yielded more OTUs, may also account for the discrepancies.
There are increasing evidences based on animal studies to suggest a possible link between alteration of gastric 
microbiota and gastric cancer development. In germ-free mice studies, it was shown that the lack of commensal 
flora delays the development of intraepithelial neoplasia, suggesting the importance of gastric microbiota in the 
promotion of gastric carcinogenesis in achlorhydric stomach14. The presence of intestinal flora was also found to 
enhance the inflammatory responses in the stomach in HP infected mice, which may promote the development of 
gastric atrophy and neoplasia development15. Results from human study further suggested that the lower micro-
bial richness in upper digestive tract was associated with lower pepsinogen I/II ratio, which is a gastric cancer 
predisposing state9. The findings of this study may open up another area of research on the potential reversibility 
of gastric microbiome by treatment of HP.
Figure 4. Changes in OTU abundance before and after HP eradication. The abundance distribution of OTUs 
were significantly different before and after HP-eradication. OTUs were showed in the same order as Fig. 3c. 
Blue indicates before HP-eradication group while red indicates after HP-eradication group. The meaning of box 
is the same with Fig. 2a.
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This study however had limitations. First, whilst it is believed that the gastric microbiota is dynamic and can 
be influenced by many external factors such as drug or diet16, we have excluded subjects with recent intake of pro-
ton pump inhibitor (PPI), non-steroidal anti-inflammatory drug (NSAID) or aspirin. As all biopsies were taken 
at fasting state during endoscopy, the potential influence by meal was kept to a minimum. Although we have 
taken serial biopsies from patients with HP infection, we have not taken serial biopsies from those without HP 
infection to determine the stability of gastric microbiota over time. However, there are ethical issues in repeating 
biopsy in those with normal gastric histology and no HP infection. Second, data form this study that based on 
next generation sequencing could only produce the distribution or relative abundance of different bacteria in the 
stomach. Actual quantitative determination of individual bacteria in different samples is not possible and further 
quantitative techniques such as PCR are needed for this specific purpose.
In conclusion, we showed that HP dominated the gastric microbiota in those with HP infection resulting 
in reduced bacterial diversity and alteration in the relative abundance of other bacterial species. Eradication of 
HP restored the bacterial diversity and composition of bacteria to levels similar to HP negative subjects. During 
progression from HP gastritis to IM and cancer, cancer samples had reduction in bacterial diversity and enhance-
ment of certain bacterial species. Further studies are needed to determine whether modulation of gastric micro-
biota could potentially alter the risk of progression to gastric cancer in HP infected individuals.
Methods
Patients and samples. Study subjects were enrolled from adult patients who underwent upper gastrointes-
tinal endoscopy in the Queen Mary Hospital of Hong Kong. We recruited patients with HP associated gastritis 
and different gastric histological changes including gastric IM and GC. Age-matched HP-negative subjects were 
recruited as negative control. Patients who were found to have active gastroduodenal ulcers on endoscopy were 
excluded. We also excluded patients who were taking acid suppressive therapy including PPIs and histamine 
(H2)-receptor blocker, NSAIDs, anti-coagulants, anti-platelet medications or had taken antibiotics within recent 
four weeks. Individuals who had previously undergone upper gastrointestinal endoscopy, prior gastric surgery or 
had received HP eradication treatment were excluded.
During upper gastrointestinal endoscopy, gastric biopsies were obtained from the antrum and corpus of the 
stomach in patients without GC for rapid urease test, histological examination and DNA extraction. H. pylori 
infection was defined by a positive rapid urease test and/or visualization of the bacteria on histological exami-
nation. Targeted biopsies were taken from those with endoscopic evidence of IM. Diagnosis of IM and GC were 
subsequently verified by histological examination. In patients with GC, biopsies were taken from the tumor and 
adjacent non-cancerous area. Gastric biopsy samples were either stored in 10% buffered formalin for histological 
examination or immediately immerged in RNALater® solution (Life Technologies, Carlsbad, USA) and then 
stored at − 80 °C for subsequent DNA extraction.
All HP infected patients were given a one-week course of eradication therapy consisting of esomeprazole 
20 mg, amoxicillin 1 g and clarithromycin 500 mg, all given twice daily. Patients who were allergic to penicillin 
were given metronidazole 400 mg twice daily instead of amoxicillin. Eight weeks after completion of the HP erad-
ication treatment, they were invited for repeat endoscopy and gastric biopsy.
Consent and Institutional Review Board. All patients provided written informed consent for participa-
tion in this study. The study protocol was approved by the Institutional Review Board of the University of Hong 
Kong and the Hospital Authority-Hong Kong West Cluster (UW 11-354). The study was performed in accordance 
with the Declaration of Helsinki.
DNA Extraction, Purification and Solexa Illumina Sequencing. Total DNA was extracted from the 
gastric biopsies using the QIAGEN DNeasy Kit (QIAGEN, Venlo, Netherlands). Sequencing works were per-
formed by the Illumina MiSeq sequencer (Illumina, San Diego, USA). The KAPA HiFi HotStart ReadMix PCR 
Kit (Kapa Biosystems) and Nextera XT Index Kit FCD-131-1001 (Illumina) were used for PCR. These libraries 
were then cleaned up and quantified using the KAPA Library Quantification Kit KK4835 for Illumina sequencing 
platforms (Kapa Biosystems). The MiSeq Reagent Kits v3 MS-102-3003 (Illumina) together with PhiX Control v3 
(Illumina) were used for sequencing.
Sequencing Data Processing. Trimmomatic17 was used to filter low quality reads and adapter sequences 
with parameters MAXINFO: 40:0.38, which balanced the quality and reads length. PEAR18 was then used to 
merge the paired-end reads with parameters -t 170 -q 20 -u 0. Primer sequences attached to merge reads were 
identified by BLAT19 alignment and trimmed. Subsequently, these reads were processed with the UPARSE pro-
gram20 to detect chimera sequences and clustered into operational taxonomic units (OTUs) at 97% sequence 
similarity.
For taxonomic assignment, the most abundant sequences were chosen as the representative sequences of 
corresponding OTUs. The taxonomic annotation of representative sequences was deemed as the taxonomic anno-
tation of OTUs. To obtain robust taxonomic annotation, both RDP classifier21 and UCLUST (version 1.2.22)22 
methods implemented in QIIME23 were used. The reference database used was Green gene database (release 
13_8)24. The default parameters (the confidence cutoff of RDP is 0.8, and the identity cutoff of UCLUST is 97%) 
were used for this step.
The rarefaction analysis was performed using QIIME to evaluate the effect of sequencing depth. The sampling 
started from 88 sequences per sample, with the step of 400 sequences, ended at 10,088 sequences per sample. Each 
step was repeated 1,000 times. Observed species number and Chao 1 index were calculated. To reduce the effects 
of various sequencing depth, the sequencing data were subsampled to 10,088 reads (the minimum sampling 
size) to calculate the Shannon index and phylogenetic diversity25 index. Similarly, the unweighted and weighted 
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unifrac distances were also calculated based on the subsampled dataset. Another two distance metrics, the root 
Jensen-Shannon divergence (rJSD)26 and Bray-Curtis dissimilarity were calculated based on the normalized 
OTUs relative abundance table. Principle coordinate analysis (PCoA) was performed on rJSD distance matrix. 
Hierarchical clustering was performed on these four distance matrixes with ward method. The same analysis was 
conducted after removing HP OTUs.
Statistical Analysis. PERMANOVA27 was implemented to evaluate the features associated with the 
sequencing data. These features included age, gender, HP state, sampling location, and HP-eradication. LEfSe28 
was used to identify the biomarkers significantly enriched in different histological group. Wilcoxon rank-sum test 
(Mann-Whitney test) was performed to infer the significance difference of diversity and microbial compositions 
between different histological states. Paired Wilcoxon rank sum test was used to identify the significant changes 
of taxa in pre- and post-eradication samples. Spearman correlation coefficient was used to evaluate the degree of 
association.
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